Atossa Therapeutics
ATOS
#9776
Rank
NZ$74.46 M
Marketcap
NZ$8.65
Share price
-0.79%
Change (1 day)
588.98%
Change (1 year)

Atossa Therapeutics (ATOS) Fails to deliver data

Key failure to deliver metrics for Atossa Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atossa Therapeutics (ATOS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atossa Therapeutics (ATOS) - since 2026

Volume in USD (price x number of shares), data since 2026

Atossa Therapeutics (ATOS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$0.83 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
NZ$37.69 MNZ$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$26.9 MNZ$56.13 M๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$5.19 MNZ$33 M๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$0.05 MNZ$13.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$2.96 MNZ$5.82 M๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
N/ANZ$0.22 M๐Ÿ‡บ๐Ÿ‡ธ USA